On date, Tiger Aesthetics Medical, LLC emerged as the successful bidder for certain assets used in Sientra’s breast reconstruction and augmentation business.This development comes as part of Sientra Inc’s Section 363 sales auction, where the company sought to sell off assets related to its breast implant business.
Sientra Inc is a company that operates in the medical aesthetics industry, specializing in breast implants.With 11.290699 million shares outstanding and a current price of $0.174 per share, the company has made strategic decisions to streamline its operations and focus on core areas of growth.
The winning bid by Tiger Aesthetics Medical, LLC signifies a significant milestone for both companies.Tiger Aesthetics Medical, LLC will now have the opportunity to leverage Sientra’s assets to further enhance its position in the breast reconstruction and augmentation market.This acquisition is expected to strengthen Tiger Aesthetics Medical, LLC’s capabilities and offerings in the aesthetic medicine field.
Overall, the completion of the Section 363 sales auction and the selection of Tiger Aesthetics Medical, LLC as the winning bidder mark a pivotal moment for both Sientra Inc and Tiger Aesthetics Medical, LLC.This strategic move is aligned with the industry trends and is poised to drive growth and innovation in the medical aesthetics sector.
Sientra Announces Completion and Winning Bidders of its Section 363 Sales Auction
Comments